 | • レポートコード：MRC23Q36247 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の膵臓がん転移治療市場について調査・分析し、世界の膵臓がん転移治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（化学療法、標的療法、その他）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Lilly、Merck、Celgene、BioLineRx、AstraZeneca、Roche、Amgen、Pfizer、Nantkwest, Incなどが含まれています。世界の膵臓がん転移治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、膵臓がん転移治療市場規模を推定する際に考慮しました。本レポートは、膵臓がん転移治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、膵臓がん転移治療に関するビジネス上の意思決定に役立てることを目的としています。 ・膵臓がん転移治療市場の概要 - 膵臓がん転移治療のタイプ別セグメント - 世界の膵臓がん転移治療市場規模：タイプ別分析（化学療法、標的療法、その他） - 膵臓がん転移治療の用途別セグメント - 世界の膵臓がん転移治療市場規模：用途別分析（病院、クリニック、その他） - 世界の膵臓がん転移治療市場規模予測（2018年-2029年） ・膵臓がん転移治療市場の成長トレンド - 膵臓がん転移治療の地域別市場規模（2018年-2029年） - 膵臓がん転移治療市場ダイナミクス - 膵臓がん転移治療の業界動向 - 膵臓がん転移治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：化学療法、標的療法、その他 - 世界の膵臓がん転移治療のタイプ別市場規模（2018年-2023年） - 世界の膵臓がん転移治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界の膵臓がん転移治療の用途別市場規模（2018年-2023年） - 世界の膵臓がん転移治療の用途別市場規模（2024年-2029年） ・膵臓がん転移治療の地域別市場規模 - 北米の膵臓がん転移治療市場規模（2018年-2029年） - アメリカの膵臓がん転移治療市場規模（2018年-2029年） - ヨーロッパの膵臓がん転移治療市場規模（2018年-2029年） - アジア太平洋の膵臓がん転移治療市場規模（2018年-2029年） - 中国の膵臓がん転移治療市場規模（2018年-2029年） - 日本の膵臓がん転移治療市場規模（2018年-2029年） - 韓国の膵臓がん転移治療市場規模（2018年-2029年） - インドの膵臓がん転移治療市場規模（2018年-2029年） - オーストラリアの膵臓がん転移治療市場規模（2018年-2029年） - 中南米の膵臓がん転移治療市場規模（2018年-2029年） - 中東・アフリカの膵臓がん転移治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Lilly、Merck、Celgene、BioLineRx、AstraZeneca、Roche、Amgen、Pfizer、Nantkwest, Inc ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Pancreatic Cancer Metastasis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Pancreatic Cancer Metastasis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pancreatic Cancer Metastasis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Pancreatic Cancer Metastasis Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Pancreatic Cancer Metastasis Treatment include Lilly, Merck, Celgene, BioLineRx, AstraZeneca, Roche, Amgen, Pfizer and Nantkwest, Inc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pancreatic Cancer Metastasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pancreatic Cancer Metastasis Treatment.
The Pancreatic Cancer Metastasis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pancreatic Cancer Metastasis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pancreatic Cancer Metastasis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Lilly
Merck
Celgene
BioLineRx
AstraZeneca
Roche
Amgen
Pfizer
Nantkwest, Inc
Segment by Type
Chemotherapy
Targeted Therapy
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pancreatic Cancer Metastasis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Cancer Metastasis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pancreatic Cancer Metastasis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Cancer Metastasis Treatment Market Perspective (2018-2029)
2.2 Pancreatic Cancer Metastasis Treatment Growth Trends by Region
2.2.1 Global Pancreatic Cancer Metastasis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pancreatic Cancer Metastasis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Pancreatic Cancer Metastasis Treatment Market Dynamics
2.3.1 Pancreatic Cancer Metastasis Treatment Industry Trends
2.3.2 Pancreatic Cancer Metastasis Treatment Market Drivers
2.3.3 Pancreatic Cancer Metastasis Treatment Market Challenges
2.3.4 Pancreatic Cancer Metastasis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Cancer Metastasis Treatment Players by Revenue
3.1.1 Global Top Pancreatic Cancer Metastasis Treatment Players by Revenue (2018-2023)
3.1.2 Global Pancreatic Cancer Metastasis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Pancreatic Cancer Metastasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Cancer Metastasis Treatment Revenue
3.4 Global Pancreatic Cancer Metastasis Treatment Market Concentration Ratio
3.4.1 Global Pancreatic Cancer Metastasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Metastasis Treatment Revenue in 2022
3.5 Pancreatic Cancer Metastasis Treatment Key Players Head office and Area Served
3.6 Key Players Pancreatic Cancer Metastasis Treatment Product Solution and Service
3.7 Date of Enter into Pancreatic Cancer Metastasis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Cancer Metastasis Treatment Breakdown Data by Type
4.1 Global Pancreatic Cancer Metastasis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Type (2024-2029)
5 Pancreatic Cancer Metastasis Treatment Breakdown Data by Application
5.1 Global Pancreatic Cancer Metastasis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
6.2 North America Pancreatic Cancer Metastasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023)
6.4 North America Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
7.2 Europe Pancreatic Cancer Metastasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023)
7.4 Europe Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
9.2 Latin America Pancreatic Cancer Metastasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023)
9.4 Latin America Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lilly
11.1.1 Lilly Company Detail
11.1.2 Lilly Business Overview
11.1.3 Lilly Pancreatic Cancer Metastasis Treatment Introduction
11.1.4 Lilly Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.1.5 Lilly Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Pancreatic Cancer Metastasis Treatment Introduction
11.2.4 Merck Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Pancreatic Cancer Metastasis Treatment Introduction
11.3.4 Celgene Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.3.5 Celgene Recent Development
11.4 BioLineRx
11.4.1 BioLineRx Company Detail
11.4.2 BioLineRx Business Overview
11.4.3 BioLineRx Pancreatic Cancer Metastasis Treatment Introduction
11.4.4 BioLineRx Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.4.5 BioLineRx Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Pancreatic Cancer Metastasis Treatment Introduction
11.5.4 AstraZeneca Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.5.5 AstraZeneca Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Pancreatic Cancer Metastasis Treatment Introduction
11.6.4 Roche Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Amgen
11.7.1 Amgen Company Detail
11.7.2 Amgen Business Overview
11.7.3 Amgen Pancreatic Cancer Metastasis Treatment Introduction
11.7.4 Amgen Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.7.5 Amgen Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pancreatic Cancer Metastasis Treatment Introduction
11.8.4 Pfizer Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 Nantkwest, Inc
11.9.1 Nantkwest, Inc Company Detail
11.9.2 Nantkwest, Inc Business Overview
11.9.3 Nantkwest, Inc Pancreatic Cancer Metastasis Treatment Introduction
11.9.4 Nantkwest, Inc Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.9.5 Nantkwest, Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details